Shilpa Medicare Ltd - Company Profile
Powered by 
All the data and insights you need on Shilpa Medicare Ltd in one report.
$295
- Save hours of research time and resources with
our up-to-date Shilpa Medicare Ltd Strategy Report
- Understand Shilpa Medicare Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Related keylists
Shilpa Medicare Clinical Trials
Determine Shilpa Medicare Ltd go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.
A sample of Shilpa Medicare Clinical Trials data
| Trial Title | Trial Identifier | Drug Name | Therapy Area | Indication | Trial Phase | Trial Status | Sponsor |
|---|---|---|---|---|---|---|---|
| Deserunt mollit sunt Lorem | GDCTWXYZ | Lorem | Lorem | Lorem | WXYZ | Planned | Pfizer Inc |
| A phase-I, open label, dose-escalation, safety, tolerability and pharmacokinetics study of Nor-ursodeoxycholic acid tablets 500 mg | GDCT0465634 | ursodiol | Gastrointestinal | Non Alcoholic Fatty Liver Disease (NAFLD); Primary Sclerosing Cholangitis | Phase I | Planned | Shilpa Medicare Ltd |
| Study to Determine Safety, Tolerability and Pharmacokinetics of Ondansetron ER Injection 100 Mg/Ml in Healthy Subjects | GDCT0460872 | ondansetron | Undisclosed | Unspecified | Phase I | Ongoing, recruiting | Shilpa Medicare Ltd |
| A Single-dose, Randomised, Two-period, Two-treatment, Two-sequence, Two-way Crossover Bioequivalence Study of Sunitinib Malate Capsules, 50 mg (Shilpa Medicare Limited, India) Compared with the Pharmacokinetic Profile of the Reference Product Sutent 50 mg Hard Capsules (Pfizer Europe MA EEIG, Belgium) in Healthy Male Subjects under Fasted Conditions | GDCT0460630 | sunitinib malate | Oncology | Gastrointestinal Stromal Tumor (GIST); Metastatic Renal Cell Carcinoma; Neuroendocrine Gastroenteropancreatic Tumors (GEP-NET) | Phase I | Completed | Shilpa Medicare Ltd |
Feature
GlobalData’s Clinical Trials database (CTDB) is a highly comprehensive source of Clinical Trials.
The database covers planned, ongoing, completed and terminated/suspended/withdrawn clinical trials.
Clinical Trials database provides intelligence on global clinical trials for all indications. The data is sourced from:
- 250+ clinical trial registries
- 200+ scientific and investor conferences, company pipelines, press releases, and SEC filings.
Benefit
The Clinical Trials database collects information on various parameters to provide a Clinical Trial overview as well as Clinical Trial details, Drug details, Patient details, Trial Results, Location(s)/Sponsor(s) and Contact Detail(s).
Access:
- Detailed trial information.
- Drug information.
- Patient information, including inclusion and exclusion criteria.
- Trial results, as reported in the public domain.
- Biomarkers used for patient stratification/selection & outcome measures.
- Enrolment parameters.
- Investigators involved in clinical trials.
- Trials sites and locations.
- Contact information.
Value
Competitive Activity – keep an eye on planned or ongoing trials, as well as the trials currently recruiting and who is sponsoring them.
Geographic Analysis - see where trials are being run.
Trend Analysis - view top sponsors, indications, phase, status and more with Trial Analytics.
Find information on trials contacts, as well as Site and Investigator information.
Get information on trial successes and failures.
Get intelligence on CROs engaged in clinical trials.
Use as a business development tool for CROs.
Premium databases is part of our industry range of products
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer